Earlier published studies have shown that the TNFAIP8L3 protein can promote cell viability and induce drug resistance, consequently promoting the development and progression of cancer (Fayngerts et al., 2014; Day et al., 2017). This evidence concerns the gene TIPE3 and cancer.